Chemotherapy and hemostasis disorders

Cancer patients are at risk of developing arterial and venous thrombosis during chemotherapy (CT) and after its cessation. A prothrombotic risk may arise via pathogenetic pathways such as activation of external and internal coagulation pathways, decreased anticoagulant levels, platelet activation, f...

Full description

Bibliographic Details
Published in:	Акушерство, гинекология и репродукция
Main Authors:	E. V. Slukhanchuk, V. O. Bitsadze, A. G. Solopova, J. Kh. Khizroeva, K. N. Grigoreva, N. R. Gashimova, N. A. Makatsariya, D. V. Blinov, V. N. Galkin, A. Yu. Shatilina, E. M. Lyadnova, N. A. Shulga, L. T. Toguzaeva, S. Morkos, J.-C. Gris, I. Elalamy, G. Gerotziafas, A. D. Makatsariya
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2025-01-01
Subjects:	cancer venous thromboembolism thrombosis chemotherapy ст
Online Access:	https://www.gynecology.su/jour/article/view/2288

Similar Items

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01)

Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19
by: A. D. Makatsariya, et al.
Published: (2021-11-01)

Hemostasis parameters as prognostic biomarkers in gynecological cancer patients
by: E. V. Slukhanchuk, et al.
Published: (2023-05-01)

How to reduce a risk of venous thromboembolism while taking combined oral contraceptives
by: V. O. Bitsadze, et al.
Published: (2023-07-01)

Haemostasis and metastasis: anticoagulants therapeutic potential in ovarian cancer
by: A. V. Vorobev, et al.
Published: (2025-07-01)

Neutrophil extracellular traps as markers of thromboinflammation in the pathogenesis of female genital tract and breast malignant neoplasms
by: E. V. Slukhanchuk, et al.
Published: (2022-09-01)

Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology
by: A. D. Makatsariya, et al.
Published: (2021-09-01)

Venous and arterial thromboses in ART programs: epidemiology and preventive strategies
by: V. O. Bitsadze, et al.
Published: (2025-07-01)

An impact of neutrophil extracellular traps to the prothrombotic state and tumor progression in gynecological cancer patients
by: E. V. Slukhanchuk, et al.
Published: (2023-03-01)

Dysregulated platelet function in COVID-19 patients
by: N. R. Gashimova, et al.
Published: (2023-01-01)

Recurrent thrombosis in malignant neoplasms: clinical significance of long-term anticoagulant prophylaxis
by: A. V. Vorobеv, et al.
Published: (2025-05-01)

Anticoagulants: dose control methods and inhibitors
by: V. O. Bitsadze, et al.
Published: (2022-05-01)

Clinical significance for assessing adaptive hemostasis changes during multiple pregnancy after in vitro fertilization
by: F. Е. Yagubova, et al.
Published: (2024-05-01)

The concept of thromboinflammation underlying thrombotic complications, tumor progression and metastasis in gynecological cancer patients
by: A. D. Makatsariya, et al.
Published: (2024-09-01)

What has changed over the year in the prevention of venous thromboembolic events in pregnant women and puerperas?
by: V. O. Bitsadze, et al.
Published: (2023-09-01)

Platelets, thrombo-inflammation and cancer
by: E. V. Slukhanchuk, et al.
Published: (2022-01-01)

HEMOSTASIS ABNORMALITIES AND MASSIVE OBSTETRIC BLEEDING
by: A. D. Makatsariya, et al.
Published: (2016-06-01)

HEART RHYTM DISORDERS AND THROMBOSIS. ANTICOAGULANT THERAPY OF CARDIAC ARRHYTHMIAS IN PREGNANCY
by: A. D. Makatsariya, et al.
Published: (2016-06-01)

Genetic thrombophilia and antiphospholipid antibodies in women with early and late preeclampsia: a retrospective cohort study
by: A. S. Antonova, et al.
Published: (2025-03-01)

Laboratory monitoring of COVID-19 patients and importance of coagulopathy markers
by: J. H. Khizroeva, et al.
Published: (2020-07-01)

Intrauterine activation of the fetal immune system in response to maternal COVID-19
by: N. R. Gashimova, et al.
Published: (2023-05-01)

Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course
by: A. D. Makatsariya, et al.
Published: (2025-03-01)

THROMBOPHILIA AND THROMBOEMBOLIC COMPLICATIONS ASSOCIATED WITH USE OF ASSISTIVE REPRODUCTIVE TECHNOLOGIES
by: S. V. Akinshina, et al.
Published: (2016-06-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Antiphospholipid antibodies as a potential factor of tumor progression
by: Z. D. Aslanova, et al.
Published: (2024-03-01)

The role of neutrophil extracellular traps in cancer progression and thrombosis development
by: J. Kh. Khizroeva, et al.
Published: (2024-03-01)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01)

Neutrophil extracellular traps-associated markers in malignant neoplasms of the female reproductive system after surgical treatment and adjuvant chemotherapy
by: E. V. Slukhanchuk, et al.
Published: (2023-09-01)

Features of the novel coronavirus infection in cancer patients
by: A. D. Makatsariya, et al.
Published: (2022-01-01)

Thromboinflammation in oncogynecological patients
by: E. V. Slukhanchuk, et al.
Published: (2022-11-01)

The role of platelets in antiviral immunity
by: E. V. Slukhanchuk, et al.
Published: (2022-05-01)

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
by: E. V. Slukhanchuk, et al.
Published: (2023-01-01)

Multiple pregnancy in fine arts
by: N. A. Makatsariya, et al.
Published: (2023-05-01)

COVID-19 impact on thrombotic complications in cancer patients
by: A. V. Vorobev, et al.
Published: (2024-07-01)

Novel coronavirus infection (COVID-19) and risk groups in obstetrics and gynecology
by: A. D. Makatsariya, et al.
Published: (2020-07-01)

Clinical significance of hemostasiological screening for thrombophilia in pregnant women with former thrombosis
by: J. Kh. Khizroeva, et al.
Published: (2022-11-01)

Metalloproteinases as biochemical markers of pregnancy pathology
by: K. N. Grigorieva, et al.
Published: (2022-03-01)

To a question about the necessity and indications for genetic screening in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2023-01-01)

Maternal death in the visual arts: immersion into emotional world through the great artists' paintings
by: N. A. Makatsariya, et al.
Published: (2023-07-01)

Homocysteine, cancer and oncothrombosis
by: V. O. Bitsadze, et al.
Published: (2023-09-01)